These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10757615)

  • 1. Comment on "Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64" [Med. Phys. 26, 2054-2076 (1999)].
    Lee PC; Moran BJ
    Med Phys; 2000 Mar; 27(3):619. PubMed ID: 10757615
    [No Abstract]   [Full Text] [Related]  

  • 2. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.
    Yu Y; Anderson LL; Li Z; Mellenberg DE; Nath R; Schell MC; Waterman FM; Wu A; Blasko JC
    Med Phys; 1999 Oct; 26(10):2054-76. PubMed ID: 10535622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
    Crook JM; Potters L; Stock RG; Zelefsky MJ
    Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine.
    Nath R; Anderson LL; Meli JA; Olch AJ; Stitt JA; Williamson JF
    Med Phys; 1997 Oct; 24(10):1557-98. PubMed ID: 9350711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on the "AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137" [Med. Phys. 36, 5310-5322 (2009)].
    Merrick GS; Blasko JC
    Med Phys; 2010 Jan; 37(1):404. PubMed ID: 20175504
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
    International Commission on Radiological Protection
    Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to "Comment on 'AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137'" [Med. Phys. 36, 5310-5322 (2009)].
    Nath R; Bice WS; Butler WM; Chen Z; Meigooni AS; Narayana V; Rivard MJ; Yu Y
    Med Phys; 2010 Apr; 37(4):1933. PubMed ID: 20443515
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on "Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group 43" [Med. Phys. 22, 209-234 (1995)]. American Association of Physicists in Medicine.
    Rivard MJ
    Med Phys; 1999 Nov; 26(11):2514. PubMed ID: 10587242
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of radiobiologic biochemical control in a large permanent prostate brachytherapy population from a single institution using AAPM TG-137 parameters.
    Butler WM; Stewart RR; Merrick GS
    Brachytherapy; 2011; 10(1):16-28. PubMed ID: 20149981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
    Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
    Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
    Duggan DM
    Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on "Tomosynthesis-based localization of radioactive seeds in prostate brachytherapy" [Med. Phys. 30, 3135-3142 (2003)].
    Pallikarakis N
    Med Phys; 2005 Jan; 32(1):300; author reply 301. PubMed ID: 15719981
    [No Abstract]   [Full Text] [Related]  

  • 14. [Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].
    Cosset JM; Hannoun-Lévi JM; Peiffert D; Delannes M; Pommier P; Pierrat N; Nickers P; Thomas L; Chauveinc L
    Cancer Radiother; 2013 Apr; 17(2):111-7. PubMed ID: 23478488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on "Update of AAPM Task Group no. 43 report: A revised AAPM protocol for brachytherapy dose calculations" [Med. Phys. 31, 633-674 (2004)].
    Meigooni AS; Rachabatthula V; Awan SB; Koona RA
    Med Phys; 2005 Jun; 32(6):1820-1; author reply 1822-4. PubMed ID: 16013739
    [No Abstract]   [Full Text] [Related]  

  • 16. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-ionization chamber response relative to NIST air-kerma strength standard for prostate brachytherapy seeds.
    Mitch MG; Zimmerman BE; Lamperti PJ; Seltzer SM; Coursey BM
    Med Phys; 2000 Oct; 27(10):2293-6. PubMed ID: 11099196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the assay of brachytherapy sources.
    Yue NJ; Haffty BG; Yue J
    Med Phys; 2007 Jun; 34(6):1975-82. PubMed ID: 17654900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to "Comment on 'Dosimetry of interstitial brachytherapy sources: recommendation of the AAPM Radiation Therapy Committee Task Group 43' " [Med. Phys. 26, 2514 (1999)]. American Association of Physicists in Medicine.
    Meigooni AS; Nath R
    Med Phys; 2000 Jan; 27(1):265. PubMed ID: 10659766
    [No Abstract]   [Full Text] [Related]  

  • 20. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
    Cosset JM; Pinillos-Ashton L; Mettler F;
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S50-5. PubMed ID: 15679247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.